you are here:

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
308,222
  • Prev. Close

    859.90

  • Open Price

    814.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
5,415,702
  • Prev. Close

    859.80

  • Open Price

    814.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

Ranbaxy Laboratories is not traded on NSE in the last 30 days

Financials

2020 2019 2018 2017 2016
Quarterly Results of Ranbaxy Laboratories (in Rs. Cr.) Dec '14 Sep '14 Jun '14 Mar '14 Dec '13  
Net Sales/Income from operations 956.52 1,272.69 2,116.98 1,224.59 1,327.64  
Other Operating Income 53.33 46.23 61.65 27.43 38.93  
Total Income From Operations 1,009.85 1,318.91 2,178.63 1,252.02 1,366.56  
EXPENDITURE  
Consumption of Raw Materials 314.13 335.94 280.73 394.87 432.75  
Purchase of Traded Goods 228.86 227.01 184.27 224.77 219.36  
Increase/Decrease in Stocks 46.07 101.17 102.74 3.29 -82.70  
Power & Fuel -- -- -- -- --  
Employees Cost 271.89 279.67 254.74 226.27 271.91  
depreciat 54.81 60.15 65.65 49.98 45.85  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 500.41 530.80 429.76 440.48 591.29  
P/L Before Other Inc. , Int., Excpt. Items & Tax -406.32 -215.82 860.74 -87.64 -111.90  
Other Income 17.75 20.02 25.76 636.50 20.60  
P/L Before Int., Excpt. Items & Tax -388.56 -195.80 886.50 548.86 -91.30  
Interest 149.31 136.82 141.91 110.85 118.39  
P/L Before Exceptional Items & Tax -537.87 -332.63 744.59 438.02 -209.69  
Exceptional Items -27.27 -35.63 19.77 490.41 -186.28  
P/L Before Tax -565.14 -368.26 764.36 928.43 -395.96  
Tax 855.35 -- 9.24 30.57 --  
P/L After Tax from Ordinary Activities -1,420.49 -368.26 755.12 897.86 -395.96  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period -1,420.49 -368.26 755.12 897.86 -395.96  
Equity Share Capital 212.24 211.95 211.78 211.66 211.55  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -33.47 -8.69 17.83 21.22 -9.36  
Diluted EPS -33.47 -8.69 17.80 21.19 -9.36  
EPS After Extra Ordinary  
Basic EPS. -33.47 -8.69 17.83 21.22 -9.36  
Diluted EPS. -33.47 -8.69 17.80 21.19 -9.36  
Public Share Holding  
No Of Shares (Crores) 15.63 14.93 14.49 14.88 14.80  
Share Holding (%) 36.77 35.22 34.18 35.11 34.93  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). 26.87 26.87 26.87 26.87 26.87  
- Per. of shares (as a % of the total sh. of prom. and promoter group). 100.00 100.00 100.00 100.00 100.00  
- Per. of shares (as a % of the total Share Cap. of the company). 63.22 63.37 63.40 63.41 63.41  
Source : Dion Global Solutions Limited